Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Exenatide 2 MG; Drug: Dapagliflozin 10 MG Sponsor: Consano Clinical Research, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials